Acrivon Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ACRV and other ETFs, options, and stocks.About ACRV
Acrivon Therapeutics, Inc. develops drugs for clinical treatment. Its unique precision medicine platform is Acrivon Predictive Precision Proteomics (AP3).
CEOPeter Blume-Jensen
CEOPeter Blume-Jensen
Employees78
Employees78
HeadquartersWatertown, Massachusetts
HeadquartersWatertown, Massachusetts
Founded2018
Founded2018
Employees78
Employees78
ACRV Key Statistics
Market cap75.10M
Market cap75.10M
Price-Earnings ratio-1.11
Price-Earnings ratio-1.11
Dividend yield—
Dividend yield—
Average volume387.25K
Average volume387.25K
High today$2.46
High today$2.46
Low today$2.31
Low today$2.31
Open price$2.43
Open price$2.43
Volume338.95K
Volume338.95K
52 Week high$8.00
52 Week high$8.00
52 Week low$1.05
52 Week low$1.05
Stock Snapshot
With a market cap of 75.1M, Acrivon Therapeutics(ACRV) trades at $2.43. The stock has a price-to-earnings ratio of -1.11.
On 2025-12-07, Acrivon Therapeutics(ACRV) stock traded between a low of $2.31 and a high of $2.46. Shares are currently priced at $2.43, which is +5.2% above the low and -1.2% below the high.
The Acrivon Therapeutics(ACRV)'s current trading volume is 338.95K, compared to an average daily volume of 387.25K.
In the last year, Acrivon Therapeutics(ACRV) shares hit a 52-week high of $8.00 and a 52-week low of $1.05.
In the last year, Acrivon Therapeutics(ACRV) shares hit a 52-week high of $8.00 and a 52-week low of $1.05.
Analyst ratings
100%
of 8 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own ACRV. This list is generated using Robinhood data, and it’s not a recommendation.